The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib

Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595883/
https://www.ncbi.nlm.nih.gov/pubmed/34785656
http://dx.doi.org/10.1038/s41419-021-04320-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595883/
https://www.ncbi.nlm.nih.gov/pubmed/34785656
http://dx.doi.org/10.1038/s41419-021-04320-4

Ejemplares similares